RAFAEL HOLDINGS, INC. Debt Securities, Trading, Unrealized Loss
RAFAEL HOLDINGS, INC. (RFL) reported Debt Securities, Trading, Unrealized Loss of $30.00 thousand for the 3-month period ending 2024-10-31, per its 10-Q filed 2024-12-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DebtSecuritiesTradingUnrealizedLoss · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. debt securities, trading, unrealized loss for the quarter ending 2024-10-31 was $30.00K.
- RAFAEL HOLDINGS, INC. debt securities, trading, unrealized loss for the quarter ending 2024-07-31 was -$57.00K.
- RAFAEL HOLDINGS, INC. debt securities, trading, unrealized loss for fiscal 2024 was $37.00K, a 99.21% decline from fiscal 2023.
- RAFAEL HOLDINGS, INC. debt securities, trading, unrealized loss for fiscal 2023 was $4.66M.
| Period end | Debt Securities, Trading, Unrealized Loss 3 month | Debt Securities, Trading, Unrealized Loss 6 month | Debt Securities, Trading, Unrealized Loss 9 month | Debt Securities, Trading, Unrealized Loss 12 month |
|---|---|---|---|---|
| 2024-10-31 | $30.00K 10-Q · filed 2024-12-11 | -$27.00K derived: sum of 2 quarters · filed 2024-12-20 | ||
| 2024-07-31 | -$57.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $37.00K 10-K/A · filed 2024-12-20 | ||
| 2024-04-30 | $94.00K 10-Q · filed 2024-06-14 | |||
| 2023-07-31 | $4.66M 10-K/A · filed 2024-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |